Buyer Products Sample Clauses

Buyer Products. (a) Since January 1, 1991, there have been no written notices, citations, or decisions by any governmental authority that any product produced, manufactured, or marketed at any time by Buyer or its Subsidiaries (collectively, the "BUYER PRODUCTS") is defective or fails to meet any applicable standards promulgated by such governmental authority. Except as would not reasonably be expected to have, individually or in the aggregate, a Buyer Material Adverse Effect, Buyer and its Subsidiaries are in compliance with the laws, regulations, policies, procedures, and specifications applicable to them with respect to the design, manufacture, labeling, testing, and inspection of the Buyer Products in the United States and the operation of manufacturing facilities in the United States promulgated by the FDA or any other governmental authority that has jurisdiction over the design, manufacture, labeling, testing, and inspection of the Buyer Products and the operation of manufacturing facilities in the United States, and have complied with the laws, regulations, policies, procedures, and specifications applicable to Buyer and its Subsidiaries in any jurisdiction outside the United States with respect to the design, manufacture, labeling, testing, and inspection of the Buyer Products and the operation of manufacturing facilities outside of the United States. Since January 1, 1991, there have been no recalls, field notifications, or seizures ordered or, to the knowledge of Buyer, threatened by any governmental authority with respect to any of the Buyer Products, and Buyer has not independently engaged in such recalls or field notifications. Buyer has not received any warning letter or Section 305 notice from the FDA.
Sample 1Sample 2
AutoNDA by SimpleDocs
Buyer Products. 37 Section 4.19 Anti-Fraud Statutes.........................................38 Section 4.20 Opinion of Financial Adviser................................38 Section 4.21
Sample 1Sample 2
Buyer Products. 4.18(a) Buyer Proprietary Rights..................................................4.11
Sample 1Sample 2
Buyer Products. As of the Effective Date, Impress shall supply to Buyer, and Buyer shall purchase from Impress, all those Products, as defined in the Supply Agreement, that relate to, or are used in, the Business (the “Buyer Products”) pursuant to the terms of the Supply Agreement. A list of current Buyer Products for the Business is set forth on Exhibit B which includes (a) the current invoice price, (b) the amounts to be used in calculating the Annual Net Adjusting Payment described below, (c) the Profit Bank, and (d) the annual Baseline Volume.
Sample 1
Buyer Products. Buyer has disclosed to counsel for the Companies any pharmaceutical product under development, pending or approved, manufactured, marketed, distributed, sold, licensed or introduced into commerce by Buyer or any of its controlled Affiliates, in each case, as of October 6, 2014.
Sample 1
Buyer Products. For existing products published by WCFC, but owned by Buyers (i.e. "The Secret Millionaire"), Buyers shall pay WCFC an additional amount consisting of an aggregate of: (i) WCFC's costs in publishing such products; (ii) an additional twenty five percent (25%); and (iii) shipping costs. The parties may agree by separate written amendment to reduce this amount to 50% of WCFC's costs in publishing such products if Buyers can demonstrate to WCFC's satisfaction that said products are being sold for a nominal amount or provided free of charge to customers pursuant to promotional activities of Buyers which result in royalties to Sellers.
Sample 1

Related to Buyer Products

  • Other Products After clinical or other evidence, provided in writing [***] to Company, demonstrating the practicality of a particular market or use within the LICENSED FIELD which is not being developed or commercialized by Company, Company shall either provide JHU with a reasonable development plan and start development or attempt to reasonably sublicense the particular market or use to a third party. If within six (6) months of such notification [***] Company has not initiated such development efforts or sublicensed that particular market or use, JHU may terminate this license for such particular market or use. This Paragraph shall not be applicable if Company reasonably demonstrates to JHU that commercializing such LICENSED PRODUCT(S) or LICENSED SERVICE(S) or granting such a sublicense in said market or use would have a potentially adverse commercial effect upon marketing or sales of the LICENSED PRODUCT(S) developed and being sold by Company.

  • Products 1.1. The information (including but not limited to the quantity, rated hashrate, unit price (“Unit Price”), total price for one item (“Total Price (One Item)”), total price for all the items (“Total Purchase Price”) of Products to be purchased by Party B from Party A is as follows (“Products”):

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • API A. Reliant shall supply to Cardinal Health for Manufacturing and Packaging, at Reliant’s sole cost, the API and applicable reference standards in quantities sufficient to meet Reliant’s requirements for each Product as further set forth in Article 4. Prior to delivery of any of the API or reference standard to Cardinal Health for Manufacturing and Packaging, Reliant shall provide to Cardinal Health a copy of the API Material Safety Data Sheet (“MSDS”), as amended, and any subsequent revisions thereto. Reliant shall supply the API, reference standards, and Certificate of Analysis FOB the Facility no later than thirty (30) days before the scheduled Manufacture Date upon which such API will be used by Cardinal Health. Upon receipt of the API, Cardinal Health shall conduct identification testing of the API. Cardinal Health shall use the API solely and exclusively for Manufacturing and Packaging under this Agreement. The maximum volume of API that Reliant supplies to Cardinal Health shall not exceed the amount reflected in the Firm Commitment and the next six (6) months of the Rolling Forecast.

  • Manufacture of Products All Products marketed through Grantor's Web ------------------------- Site shall be manufactured, packaged, prepared, and shipped in accordance with the specifications and requirements described on Exhibit A hereto as it may be modified from time to time. Quality control standards relating to the Product's weight, color, consistency, micro-biological content, labeling and packaging are also set forth on Exhibit A. In the event that Exhibit A is incomplete, Products shall be manufactured and shipped in accordance with industry standards.

  • Borrower Products Except as described on Schedule 5.11, no Intellectual Property owned by Borrower or Borrower Product has been or is subject to any actual or, to the knowledge of Borrower, threatened litigation, proceeding (including any proceeding in the United States Patent and Trademark Office or any corresponding foreign office or agency) or outstanding decree, order, judgment, settlement agreement or stipulation that restricts in any manner Borrower’s use, transfer or licensing thereof or that may affect the validity, use or enforceability thereof. There is no decree, order, judgment, agreement, stipulation, arbitral award or other provision entered into in connection with any litigation or proceeding that obligates Borrower to grant licenses or ownership interest in any future Intellectual Property related to the operation or conduct of the business of Borrower or Borrower Products. Borrower has not received any written notice or claim, or, to the knowledge of Borrower, oral notice or claim, challenging or questioning Borrower’s ownership in any Intellectual Property (or written notice of any claim challenging or questioning the ownership in any licensed Intellectual Property of the owner thereof) or suggesting that any third party has any claim of legal or beneficial ownership with respect thereto nor, to Borrower’s knowledge, is there a reasonable basis for any such claim. Neither Borrower’s use of its Intellectual Property nor the production and sale of Borrower Products infringes the Intellectual Property or other rights of others.

  • Product The term “

  • Company Products Schedule 2.10(d) of the Company Disclosure Letter lists all Company Products, and for each such product or feature (and each version thereof) identifying its release date.

  • Defective Products None of the Group Companies has manufactured, sold or supplied products which are, or were, in any material respect, faulty or defective, or which do not comply in any material respect with any representations or warranties expressly made by such Group Company, or with all applicable regulations, standards and requirements.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!